Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities
- PMID: 18786134
- DOI: 10.1111/j.1399-0004.2008.01069.x
Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities
Abstract
Anderson's disease (AD) or chylomicron retention disease (CMRD) is a rare hereditary lipid malabsorption syndrome linked to SARA2 gene mutations. We report in this study a novel mutation in two sisters for which the Sar1b protein is predicted to be truncated by 32 amino acids at its carboxyl-terminus. Because the SARA2 gene is also expressed in the muscle, heart, liver and placenta, extraintestinal clinical manifestations may exist. For the first time, we describe in this study in the two sisters muscular as well as cardiac abnormalities that could be related to the reported expression of SARA2 in these tissues. We also evaluated six other patients for potential manifestations of the SARA2 mutation. The creatine phosphokinase levels were increased in all patients [1.5-9.4 x normal (N)] and transaminases were moderately elevated in five of the eight patients (1.2-2.6 x N), probably related to muscle disease rather than to liver dysfunction. A decreased ejection fraction occurred in one patient (40%, N: 60%). The muscle, liver and placental tissues that were examined had no specific abnormalities and, in particular, no lipid accumulation. These results suggest that myolysis and other extraintestinal abnormalities can occur in AD/CMRD and that the clinical evaluation of patients should reflect this.
Similar articles
-
Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene.Metabolism. 2010 Apr;59(4):463-7. doi: 10.1016/j.metabol.2009.07.042. Epub 2009 Oct 20. Metabolism. 2010. PMID: 19846172
-
Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease).Orphanet J Rare Dis. 2011 Jan 14;6:1. doi: 10.1186/1750-1172-6-1. Orphanet J Rare Dis. 2011. PMID: 21235735 Free PMC article.
-
Anderson's disease/chylomicron retention disease in a Japanese patient with uniparental disomy 7 and a normal SAR1B gene protein coding sequence.Orphanet J Rare Dis. 2011 Nov 21;6:78. doi: 10.1186/1750-1172-6-78. Orphanet J Rare Dis. 2011. PMID: 22104167 Free PMC article.
-
[Chylomicron retention disease caused by SAR1B gene variations in 2 cases and literatures review].Zhonghua Er Ke Za Zhi. 2024 Jun 2;62(6):565-570. doi: 10.3760/cma.j.cn112140-20240301-00138. Zhonghua Er Ke Za Zhi. 2024. PMID: 38763880 Review. Chinese.
-
Chylomicron retention disease: genetics, biochemistry, and clinical spectrum.Curr Opin Lipidol. 2019 Apr;30(2):134-139. doi: 10.1097/MOL.0000000000000578. Curr Opin Lipidol. 2019. PMID: 30640893 Review.
Cited by
-
Organization of the ER-Golgi interface for membrane traffic control.Nat Rev Mol Cell Biol. 2013 Jun;14(6):382-92. doi: 10.1038/nrm3588. Nat Rev Mol Cell Biol. 2013. PMID: 23698585 Free PMC article. Review.
-
The GTPase ARFRP1 controls the lipidation of chylomicrons in the Golgi of the intestinal epithelium.Hum Mol Genet. 2012 Jul 15;21(14):3128-42. doi: 10.1093/hmg/dds140. Epub 2012 Apr 14. Hum Mol Genet. 2012. PMID: 22505585 Free PMC article.
-
Knockdown of SAR1B suppresses proliferation and induces apoptosis of RKO colorectal cancer cells.Oncol Lett. 2020 Nov;20(5):186. doi: 10.3892/ol.2020.12048. Epub 2020 Sep 3. Oncol Lett. 2020. PMID: 32952655 Free PMC article.
-
COPII and the regulation of protein sorting in mammals.Nat Cell Biol. 2011 Dec 22;14(1):20-8. doi: 10.1038/ncb2390. Nat Cell Biol. 2011. PMID: 22193160 Review.
-
Chylomicron Retention Disease: Failure to Thrive and Abdominal Distention in an Infant.JPGN Rep. 2021 Nov 29;3(1):e145. doi: 10.1097/PG9.0000000000000145. eCollection 2022 Feb. JPGN Rep. 2021. PMID: 37168760 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical